| <p>Norris Medicines Limited will hold a board meeting on November 14, 2026, at its registered office in Ankleshwar, Gujarat, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review report thereof, according to a regulatory filing with the BSE Limited. The company’s trading window for securities has been closed since October 1, 2026, and will remain so until 48 hours after the unaudited financial results are announced on the stock exchange.</p> |